| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.16B | 125.67B | 129.36B | 125.77B | 126.91B | 127.78B |
| Gross Profit | 22.50B | 23.34B | 19.84B | 24.48B | 19.23B | 15.91B |
| EBITDA | 13.61B | 14.52B | 11.61B | 16.06B | 12.16B | 9.09B |
| Net Income | 8.63B | 9.75B | 8.40B | 10.62B | 8.41B | 5.61B |
Balance Sheet | ||||||
| Total Assets | 152.05B | 155.08B | 153.02B | 147.04B | 131.74B | 128.76B |
| Cash, Cash Equivalents and Short-Term Investments | 43.74B | 42.61B | 42.17B | 48.94B | 19.65B | 31.15B |
| Total Debt | 14.19B | 14.11B | 14.99B | 15.59B | 15.04B | 17.08B |
| Total Liabilities | 37.73B | 40.01B | 52.43B | 57.50B | 51.31B | 55.64B |
| Stockholders Equity | 113.00B | 113.66B | 99.23B | 88.22B | 79.17B | 71.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.31B | -5.48B | 31.33B | -7.82B | 18.01B |
| Operating Cash Flow | 0.00 | -2.54B | -4.65B | 32.33B | 513.00M | 19.57B |
| Investing Cash Flow | 0.00 | 51.00M | -895.00M | -1.45B | -8.68B | -2.01B |
| Financing Cash Flow | 0.00 | 2.63B | -1.67B | -1.60B | -3.75B | -3.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥181.35B | 11.69 | ― | 2.81% | 8.83% | 49.49% | |
76 Outperform | ¥197.62B | 6.20 | ― | 2.72% | -2.11% | -11.31% | |
76 Outperform | ¥221.75B | 14.34 | 8.53% | 2.45% | 5.14% | -10.92% | |
76 Outperform | ¥315.97B | 9.48 | ― | 2.79% | 10.62% | 64.25% | |
70 Outperform | ¥140.98B | 9.59 | ― | 1.55% | 20.44% | 106.45% | |
68 Neutral | ¥132.91B | 11.19 | ― | 2.14% | 4.81% | -1.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |